In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- Alpha Beta T-cell and B-cell depleted allogeneic transplantation followed by Blinatumomab therapy for high-risk B-Acute Lymphoblastic Leukemia pilot study
- Blinatumomab bridging therapy in high-risk B-ALL clinical trial
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Clinical Trials - Diseases by specialty group
Late Effects and Supportive Studies 14
-
Protocol ID
- Associated disease
- Title
-
CIBMTR-13-TLEC
- Late Effects and Supportive Studies
- Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
-
COG-ACCL1333
- Late Effects and Supportive Studies
- A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B cell) Treated with Pegylated (PEG) L-Asparaginase
-
COG-ALTE07C1
- Late Effects and Supportive Studies
- Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
-
COG-ALTE11C1
- Late Effects and Supportive Studies
- Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma
-
IIT-BINGEN-TRANSITION
- Late Effects and Supportive Studies
- Evaluation of a Transition to Survivorship Program
-
IIT-BURKE-CLL
- Late Effects and Supportive Studies
- Treatment Effects in Children and Adolescent/Young Adults with Leukemia or Lymphoma
-
IIT-DOBROZSI-PRO
- Late Effects and Supportive Studies
- Patient Reported Outcome Data as a Clinical Tool in Children with Cancer
-
IIT-HOAG-PA
- Late Effects and Supportive Studies
- Using Recreational Therapy to Increase Physical Activity, Sleep, Quality of Life, and Social Connectedness in an Inpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Setting
-
IIT-ZENGA-ANTISEPSIS
- Late Effects and Supportive Studies
- A Topical Antiseptic Bundle for Decreasing Surgical Site Infection after Head Neck Cancer Surgery: Peri-operative Effects on the Oral Microbiome
-
NYMC-579
- Late Effects and Supportive Studies
- A Pilot Study in the Treatment of Refractory Adenovirus (AdV) Infection with Related Donor AdV Cytotoxic T-Lymphocytes (AdV-CTLs) in Children, Adolescents and Young Adult Recipients
-
NYMC-580
- Late Effects and Supportive Studies
- A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections with Related Donor CMV Specific Cytotoxic T-Cells (CTLs) in Children, Adolescents and Young Adult Recipients
-
NYMC-581
- Late Effects and Supportive Studies
- A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection with Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients
-
PBMTC-SUP1601
- Late Effects and Supportive Studies
- Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients with Suspected Lower Respiratory Tract Infection
-
THERAKOS-TKS-2014-001
- Late Effects and Supportive Studies
- Single-Arm Study to Assess the Efficacy of UVADEX (Methoxsalen) Sterile Solution in Conjunction with the THERAKOS CELLEX Photopheresis System in Pediatric Patients with Steroid-Refractory Acute Graft Versus Host Disease (aGvHD)
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
